LIVNLivaNova PLC同业对比
LivaNova PLC 与Electromedical & Electrotherapeutic Apparatus的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Electromedical & Electrotherapeutic Apparatus)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIVN本股 | $4.5B#2 | 42.0x#7 | 3.7x#6 | 3.3x#6 | 10.7%#11 | -483.7%#15 | 14.4%#4 | -20.0%#9 | 20.8%#3 | 4#8 | 100.4%#4 | — |
| MDT | $111.0B#1 | 23.2x#3 | 2.2x#4 | 3.1x#5 | 8.4%#12 | 3.0%#8 | 17.8%#2 | 9.7%#4 | 7.1%#4 | 8#1 | 0.2%#11 | 3.3%#1 |
| ITGR | $4.2B#3 | 30.9x#5 | 2.5x#5 | 2.3x#4 | 8.0%#13 | -14.3%#9 | 11.9%#5 | 6.1%#5 | 6.2%#5 | 8#1 | 17.2%#8 | — |
| TMDX | $2.8B#4 | 18.7x#2 | 5.7x#9 | 4.7x#8 | 37.1%#2 | 436.1%#1 | 17.9%#1 | 38.5%#2 | 45.7%#1 | 6#4 | -32.4%#13 | — |
| AXGN | $2.5B#5 | — | 9.6x#13 | 10.9x#11 | 20.2%#8 | -57.6%#13 | -3.5%#7 | -6.1%#8 | -4.8%#8 | 4#8 | 261.2%#1 | — |
| BLFS | $1.6B#6 | — | 4.2x#7 | 16.3x#12 | 28.9%#5 | 77.2%#2 | -17.3%#8 | -1.2%#7 | -4.7%#7 | 6#4 | 54.4%#6 | — |
| CNMD | $1.6B#7 | 28.0x#4 | 1.5x#3 | 1.1x#2 | 5.2%#14 | -64.4%#14 | 7.5%#6 | 4.5%#6 | 3.8%#6 | 5#6 | 0.8%#10 | 1.6%#2 |
| CBLL | $694M#8 | — | 4.9x#8 | 7.8x#10 | 36.1%#3 | -32.0%#12 | -65.6%#11 | -37.9%#10 | — | — | 29.5%#7 | — |
| CV | $357M#9 | 5.5x#1 | 17.7x#15 | 26.4x#14 | 15.3%#10 | -27.2%#11 | -188.3%#13 | -125.2%#12 | — | — | 82.9%#5 | — |
| ELMD | $343M#10 | 35.4x#6 | 7.0x#11 | 5.4x#9 | 17.0%#9 | 46.3%#3 | 15.1%#3 | 15.3%#3 | 21.2%#2 | 8#1 | 127.3%#3 | — |
| STXS | $129M#11 | — | 9.0x#12 | 4.0x#7 | 20.3%#7 | 10.0%#6 | -68.3%#12 | -150.7%#14 | -62551.6%#11 | 5#6 | -40.8%#14 | — |
| VANI | $115M#12 | — | 6.0x#10 | — | — | 13.3%#5 | — | 139.4%#1 | -1794.0%#10 | — | 1.1%#9 | — |
| OM | $91M#13 | — | 0.8x#2 | 0.8x#1 | 5.1%#15 | 36.2%#4 | -55.8%#10 | -73.1%#11 | -36.5%#9 | 4#8 | -67.4%#15 | — |
| NRXS | $81M#14 | — | 14.2x#14 | 22.8x#13 | 32.9%#4 | 5.4%#7 | -219.4%#14 | -135.7%#13 | — | — | 152.9%#2 | — |
| STEX | $77M#15 | — | 0.5x#1 | 1931.2x#15 | 122.2%#1 | -4379.9%#16 | -177735.0%#15 | -291.1%#15 | — | — | -82.7%#16 | — |
| ECOR | $51M#16 | — | — | 1.6x#3 | 27.2%#6 | -17.5%#10 | -41.1%#9 | — | — | — | -13.0%#12 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-08-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议